Strategies to minimize bone disease in renal failure

This publication has 34 references indexed in Scilit:

• 1α-Hydroxyvitamin D2 Is Less Toxic but Not Bone Selective Relative to 1α-Hydroxyvitamin D3 in Ovariectomized Rats
  Journal of Bone and Mineral Research, 2001
• Long‐term effects of intermittent oral alphacalcidol, calcium carbonate and low‐calcium dialysis (1.25 mmol L⁻¹) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis
  Journal of Internal Medicine, 1998
• Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure
  American Journal of Kidney Diseases, 1996
• Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study
  Nephrology Dialysis Transplantation, 1996
• Renal bone disease 1990: An unmet challenge for the nephrologist
  Kidney International, 1990
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• Suppression of Serum Parathyroid Hormone Levels by Intravenous Alphacalcidol in Uremic Patients on Maintenance Hemodialysis
  Nephron, 1988
• The absorption of dietary phosphorus and calcium in hemodialysis patients
  Kidney International, 1986
• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
  Journal of Clinical Investigation, 1971